Analysts expect TScan Therapeutics, Inc. to report revenue of 429,910.88 for Q3 26, against a range of 399,462.87 to 460,358.89. The most recent reported quarter, Q2 26, came in at 1.05 M, a 46.8% miss against the 1.98 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.05 M | 665,000.00 | 2.17 M | 3.08 M | 2.51 M | 2.57 M | 982,000.00 | 1.05 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.25 M | 1.49 M | 1.13 M | 1.50 M | 1.94 M | 2.74 M | 2.53 M | 2.08 M | 460,358.89 | 1.01 M | 1.04 M | 958,990.93 | 552,933.16 | 909,875.06 | 5.01 M | 6.99 M | ||||||||||
| Low Estimate | 1.16 M | 1.35 M | 934,454.77 | 1.24 M | 1.80 M | 2.42 M | 2.32 M | 1.87 M | 399,462.87 | 931,682.05 | 918,041.41 | 816,099.69 | 466,891.56 | 795,973.82 | 4.48 M | 6.27 M | ||||||||||
| Consensus Estimate | 1.20 M | 1.42 M | 1.03 M | 1.37 M | 1.87 M | 2.58 M | 2.42 M | 1.98 M | 429,910.88 | 968,873.22 | 980,643.75 | 887,545.31 | 509,912.36 | 852,924.44 | 4.75 M | 6.63 M |
Analysts expect TScan Therapeutics, Inc. to report earnings per share of -0.26 for Q3 26, against a range of -0.28 to -0.24. The most recent reported quarter, Q2 26, came in at -0.23, a 4.2% beat against the -0.24 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.25 | -0.30 | -0.26 | -0.28 | -0.28 | -0.18 | -0.22 | -0.23 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.31 | -0.32 | -0.27 | -0.33 | -0.30 | -0.25 | -0.18 | -0.23 | -0.24 | -0.19 | -0.16 | -0.16 | -0.18 | -0.14 | -0.16 | -0.15 | ||||||||||
| Low Estimate | -0.35 | -0.36 | -0.33 | -0.35 | -0.34 | -0.27 | -0.20 | -0.25 | -0.28 | -0.21 | -0.20 | -0.18 | -0.20 | -0.16 | -0.18 | -0.17 | ||||||||||
| Consensus Estimate | -0.33 | -0.34 | -0.30 | -0.34 | -0.32 | -0.26 | -0.19 | -0.24 | -0.26 | -0.20 | -0.18 | -0.17 | -0.19 | -0.15 | -0.17 | -0.16 |
Pull Wall Street consensus for TScan Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TCRX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TCRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TCRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();